In einem turbulenten Marktumfeld hat die Aktie von Mainz Biomed (NASDAQ: MYNZ) BV ein 52-Wochen-Tief erreicht und ist auf 6,12 US-Dollar gesunken. Das für innovative Krebsscreening-Technologien bekann ...
This page features the latest news about the Mainz Biomed BV stock. Mainz Biomed stock hits 52-week low at $0.18 amid market challenges In a turbulent market environment, Mainz Biomed BV (NASDAQ ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
The healthcare industry is set for growth due to the growing demand for quality treatments and ongoing progress in medical ...
At close: December 6 at 4:00:00 PM EST ...
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Orchestra BioMed has higher earnings, but lower revenue than Tandem Diabetes Care. Tandem Diabetes Care is trading at a lower price-to-earnings ratio than Orchestra BioMed, indicating that it is ...
The VERSA 1100 automated liquid handling workstation delivers true high-throughput processing, yet can still sit atop a bench. The 15 position deck accommodates a variety of configurations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback